Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sage Therapeutics Inc

+ Add to Watchlist

SG7:GR

38.960 EUR 0.360 0.92%

As of 15:36:29 ET on 03/04/2015.

Snapshot for Sage Therapeutics Inc (SG7)

Open: 38.665 Day's Range: 38.457 - 39.058 Volume: 0
Previous Close: 39.320 52wk Range: 18.700 - 39.320 1-Yr Rtn: -

Stock Chart for SG7

No chart data available.
  • SG7:GR 38.496
  • 1D
  • 1M
  • 1Y
39.320
Interactive SG7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SG7

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -2.0850
Est. PEG Ratio -
Market Cap (M EUR) 1,004.88
Shares Outstanding (M) 25.79
30 Day Average Volume 28
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SG7

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SG7

Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Jeffrey M Jonas "Jeff"President/CEOKimi IguchiChief Financial Officer
Stephen J KanesChief Medical OfficerAlbert J RobichaudChief Scientific Officer
More Company Profile & Key Executives for SG7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil